Tobacco giant Philip Morris says 265 jobs in Switzerland will be affected by restructuring plans, of which almost two-thirds of posts may be transferred to other European sites.
After much uncertainty and news speculation, Philip Morris (PMI) confirmed on Monday its restructuring plans at operational centres in Lausanne and Neuchâtel in French-speaking western Switzerland.
The firm expects 265 jobs to be affected by the changes, of which 60% may be transferred to PMI sites in Lisbon, London or Krakow. Staff have been involved in consultation talks and will be informed of the definitive changes by the end of March, PMI said.
It confirmed that the restructuring in Switzerland was linked to its plans to concentrate on smokeless products.
“These last few years we have increased the number of staff and recruited new professional profiles to focus as swiftly as possible on a smokeless future,” said Charles Bendotti, PMI’s Senior Vice President for Human Resources. He added that the multinational remains attached to its global operations centre and R&D headquarters in Switzerland.
Philip Morris International employs some 3,000 people in Switzerland. Philip Morris S.A., based in Lausanne, is responsible for sales and marketing activities in Switzerland. The lakeside city is also home to PMI’s global operations centre, employing 1,500 people. PMI’s research and development centre in Neuchâtel, employs more than 400 staff.
Swiss invention: 90-year anniversary of first T-bar ski lift
This content was published on
On Monday it will be 90 years since the world’s first T-bar ski lift went into service in Davos. This Swiss invention was an instant success.
Iran summons Swiss ambassador over US and Italy arrests
This content was published on
Iran has summoned the Swiss ambassador, who represents US interests, to protest against the arrest in the US and Italy of two Iranians.
Swisscom receives greenlight for acquisition of Vodafone Italia
This content was published on
The takeover of Vodafone Italia by Swisscom is nearing completion. All relevant authorities have now approved the €8 billion (CHF7.45 billion) deal.
Novo Nordisk stock market plunge drags down Swiss device maker Ypsomed
This content was published on
The Danish pharmaceutical giant, Novo Nordisk, faced setbacks on Friday that weighed on the share price of Swiss injection device manufacturer Ypsomed.
Swiss press react to EU deal with mix of euphoria and scepticism
This content was published on
Swiss media reaction to the agreement between Switzerland and the EU varies widely. Some are celebrating, while others worry about what is to come.
Swiss Solidarity donations to tackle child abuse top CHF4 million
This content was published on
Swiss Solidarity, the humanitarian arm of the Swiss Broadcasting Corporation (SBC), has raised over CHF4 million ($4.3 million) to tackle child abuse.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Switzerland: the land of the tobacco industry
This content was published on
Though Switzerland has not yet ratified the WHO Framework Convention on Tobacco Control, Geneva is hosting an important meeting on the treaty.
Geneva parliament votes to ban cigarette sales to minors
This content was published on
Geneva has joined most other Swiss cantons in banning the sale of cigarettes to minors and plans a ban on the sale of e-cigarettes to young people.
Will tobacco-friendly Switzerland change its tune on smoking laws?
This content was published on
Switzerland is one of a handful of countries that has not ratified a major global tobacco control treaty. Is change in the air?
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.